The Enterprise Value as of November 2025 (TTM) for Neoleukin Therapeutics, Inc. (NLTX) is -52597315.00

According to Neoleukin Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -52597315.00. This represents a change of 4.10% compared to the average of -1251529.15 of the last 4 quarters.

Neoleukin Therapeutics, Inc. (NLTX) Historical Enterprise Value (quarterly & annually)

How has NLTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Neoleukin Therapeutics, Inc. over the last ten years is 146.73M. The current -52597315.00 Enterprise Value has changed -3684.54% with respect to the historical average. Over the past ten years (40 quarters), NLTX's Enterprise Value was at its highest in in the June 2020 quarter at 700.97M. The Enterprise Value was at its lowest in in the December 2024 quarter at -57935250.00.

Neoleukin Therapeutics, Inc. (NLTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neoleukin Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neoleukin Therapeutics, Inc. (NLTX) Average Enterprise Value

How has NLTX Enterprise Value performed in the past?

The current Enterprise Value of Neoleukin Therapeutics, Inc. (NLTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neoleukin Therapeutics, Inc. (NLTX) Enterprise Value vs. Peers

How is NLTX’s Enterprise Value compared to its peers?

Neoleukin Therapeutics, Inc.’s Enterprise Value is less than Lannett Company, Inc. (546.53M), less than DMK Pharmaceuticals Corporation (-737792.00), less than Biora Therapeutics, Inc. (37.44M), less than ProSomnus, Inc. (42.48M), less than Turnstone Biologics Corp. (-8062051.00), less than Tvardi Therapeutics, Inc. (18.02M), less than COSCIENS Biopharma Inc. (-645869.00), less than Omega Therapeutics, Inc. (105.65M), less than Channel Therapeutics Corporation (11.15M), less than Centogene N.V. (70.32M),

Build a custom stock screener for Neoleukin Therapeutics, Inc. (NLTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neoleukin Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neoleukin Therapeutics, Inc. (NLTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neoleukin Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.